ArticleTranslational oncology2026

Unmasking FCGR2B as a high-grade serous ovarian cancer specific marker of immune suppression and tumor progression through multi-omics mining.

Jialu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.